Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02393599 · ClinicalTrials.gov registry record · Phase 1
Study to Assess Potential Interactions Between Intravenous Cocaine and Oral Lorcaserin
A Phase 1 study of Cocaine Abuse, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT02393599: Completed Phase 1 study of Cocaine Abuse, sponsored by National Institute on Drug Abuse (NIDA).
NCT02393599 is a Phase 1 study of Cocaine Abuse that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 20 participants, below the 916-participant average among 9 other Cocaine Abuse trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02393599, a Phase 1 study of Cocaine Abuse, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to determine if there are significant interactions between oral lorcaserin treatment concurrent with 20 and 40 mg intravenous (i.v.) cocaine infusions by measuring adverse events (AEs) and cardiovascular responses including heart rate (HR), blood pressure (BP), and electrocardiogram (ECG) (including QTc).
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Lorcaserin
- DRUG Cocaine Infusion
Study Locations (1)
Kansas
- Vince Associates Clinical Research, Inc. - Overland Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2015-05 |
| Est. Completion | 2015-09 |
| Phase | Phase 1 |
What the finished NCT02393599 record still lists
NCT02393599 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 916-participant average among 9 other Cocaine Abuse trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Cocaine Abuse appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT02393599 reports a single indexed study location in Kansas.
Frequently Asked Questions
What is clinical trial NCT02393599 about?
NCT02393599 is a clinical study titled "Study to Assess Potential Interactions Between Intravenous Cocaine and Oral Lorcaserin". The primary objective of this study is to determine if there are significant interactions between oral lorcaserin treatment concurrent with 20 and 40 mg intravenous (i.v.) cocaine infusions by measuring adverse events (AEs) and cardiovascular responses including heart rate (HR), blood pressure (BP),...
What is the current status of trial NCT02393599?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2015-05. Estimated completion is 2015-09.
What conditions does trial NCT02393599 study?
This clinical trial studies the following conditions: Cocaine Abuse.
What interventions are being tested in trial NCT02393599?
The interventions under investigation include: Placebo (DRUG), Lorcaserin (DRUG), Cocaine Infusion (DRUG).
Who is sponsoring clinical trial NCT02393599?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02393599 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cocaine Abuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02393599's enrollment target sits among peer trials
20 9th of 9 higher than 1 of 9 other Cocaine Abuse trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cocaine Abuse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CBT With Disulfiram and Contingency Management
COMPLETED · Phase 1
-
Rivastigmine and Huperzine A as Treatments for Cocaine Dependence
COMPLETED · Phase 1
-
Long Term Maintenance of Drug Abstinence
COMPLETED · Phase 1
-
Substance Abuse Pre-Treatment Screening Study
RECRUITING
-
Progesterone for the Treatment of Cocaine Dependence - 1
COMPLETED · NA
-
Effects of Aripiprazole on Cocaine Craving and Self-Administration
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia